Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Efficacy and Safety of Indomethacin in Covid-19 patients

Rajan Ravichandran, Prassana Purna, Sivakumar Vijayaragavan, Ravi Teja Kalavakollu, Shilpa Gaidhane, Ramarathnam Krishna Kumar
doi: https://doi.org/10.1101/2020.12.14.20245266
Rajan Ravichandran
aDepartment of Nephrology, MIOT International, Chennai, India and Adjunct Faculty Indian Institute of Technology Madras, Chennai India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prassana Purna
bDepartment of Pulmonology, Narayana Medical College, Nellore, Andhra Pradesh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sivakumar Vijayaragavan
cNarayana Translational Research Centre, Narayana Medical College, Nellore, Andhra Pradesh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravi Teja Kalavakollu
bDepartment of Pulmonology, Narayana Medical College, Nellore, Andhra Pradesh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shilpa Gaidhane
dDepartment of Medicine, Datta Meghe Institute of Medical Science, Wardha, Maharashtra, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramarathnam Krishna Kumar
eDepartment of Engineering Design, Indian Institute of Technology Madras, Chennai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rkkumar@iitm.ac.in
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Indomethacin, a well-known non-steroidal anti-inflammatory drug (NSAID), has in addition broad spectrum anti-viral activity in the laboratory including on SARS-Cov-2 virus. This trial is to observe the likelihood of efficacy and safety of Indomethacin in treating RT-PCR positive Covid patients

Materials and Methods The study was done in two groups. In the first group of the study, where mild and moderate patients were involved, Propensity Score Matching was used as a methodology to compare Indomethacin and paracetamol based treatments in addition to the standard protocol for treating covid-19 patients.. Blood chemistry was collected before and after the treatment. The patients were monitored every day for clinical parameters. In this part, a patient developing hypoxia was the end point. In the second group, severe patients admitted with hypoxia were treated with Indomethacin in addition to Remdesivir, and the end point was the requirement of mechanical ventilation/admission to ICU.

Results It was observed that patients treated with Indomethacin had a reduction in the number of days to become afebrile, reduction in cough and myalgia by half compared to the paracetamol set. Only one out of 72 patients in the Indomethacin arm of the first group required supplementary oxygen while 28 of the 72 patients required supplementary oxygen in the paracetamol arm. No one in the second group deteriorated enough to require mechanical ventilation. There wea no evidence of adverse reaction to indomethacin or deterioration of renal or liver function.

Conclusion Indomethacin, along with standard care, seems to provide faster symptomatic relief and prevent progression of pneumonia in Covid-19 patients. It should be considered to replace paracetamol when there is no contraindication for its use.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ISRCTN 11970082

Funding Statement

Funding for this study was provided by Mr. Kris Gopalakrishnan, Alumnus of the Indian Institute of Technology Madras. He is also the Chairman of Axilor Ventures and former executive vice chairman (former co-chairman) of Infosys.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

1. Approved 03/08/2020, Institutional Ethics Committee, Narayana Medical College (Nellore 524003, India; +91 (0)8008086119; dean{at}narayanamedicalcollege.com), ref: NMC/Ethics/Project/006/2020 2. Approved 10/10/2020, Institutional Ethics Committee, Datta Meghe Institute of Medical Sciences (Sawangi (Meghe), Wardha - 442004, Maharashtra, India; +91 (0)7152 287701; icc.dmims{at}gmail.com), ref: DMIMS(DU)/IEC/2020-21/9034

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The patient data if required can be obtained after ethics committee clearance of the hospital

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 16, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy and Safety of Indomethacin in Covid-19 patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy and Safety of Indomethacin in Covid-19 patients
Rajan Ravichandran, Prassana Purna, Sivakumar Vijayaragavan, Ravi Teja Kalavakollu, Shilpa Gaidhane, Ramarathnam Krishna Kumar
medRxiv 2020.12.14.20245266; doi: https://doi.org/10.1101/2020.12.14.20245266
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Efficacy and Safety of Indomethacin in Covid-19 patients
Rajan Ravichandran, Prassana Purna, Sivakumar Vijayaragavan, Ravi Teja Kalavakollu, Shilpa Gaidhane, Ramarathnam Krishna Kumar
medRxiv 2020.12.14.20245266; doi: https://doi.org/10.1101/2020.12.14.20245266

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8792)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (395)
  • Infectious Diseases (except HIV/AIDS) (10570)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1758)
  • Nursing (103)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (220)
  • Psychiatry and Clinical Psychology (1846)
  • Public and Global Health (3989)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)